NCT00481741View on ClinicalTrials.gov

Study of the SafeSeal(TM) Hemostasis Patch Following Percutaneous Coronary Artery and Peripheral Vascular Interventions

PHASE4CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

October 31, 2007

Study Completion Date

December 31, 2007

Conditions
Coronary Artery DiseasePeripheral Vascular Disease
Interventions
DEVICE

SafeSeal(TM) Hemostasis Patch

Trial Locations (1)

14642

University of Rochester Medical Center, Rochester

All Listed Sponsors
collaborator

MEDRAD, Inc.

INDUSTRY

lead

University of Rochester

OTHER

NCT00481741 - Study of the SafeSeal(TM) Hemostasis Patch Following Percutaneous Coronary Artery and Peripheral Vascular Interventions | Biotech Hunter | Biotech Hunter